RavenQuest BioMed Inc. Stock Canadian Securities Exchange
Equities
RQB
CA7543871080
Business Support Services
Sales 2017 | 0.11 0.15 | Sales 2018 | 1.26 1.72 | Capitalization | 58.71M 80.25M |
---|---|---|---|---|---|
Net income 2017 | -3M -4.1M | Net income 2018 | -30M -41.01M | EV / Sales 2017 * | - |
Net cash position 2017 | 3.15M 4.3M | Net Debt 2018 | 12.9M 17.63M | EV / Sales 2018 | 56,975,119 x |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-1.55
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 89.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 19-11-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 19-11-26 |
1st Jan change | Capi. | |
---|---|---|
+6.13% | 7.41B | |
-32.64% | 3.24B | |
+11.38% | 1.75B | |
-9.32% | 1.08B | |
+31.69% | 907M | |
-7.64% | 714M | |
-3.60% | 606M | |
-8.30% | 539M | |
-22.29% | 515M |